Sign in

CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company

Annovis Bio, Inc.

Sign in to watch
Ticker
ANVS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262540421
Phone
484-875-3192
Business address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
Former names
QR Pharma, Inc.
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Material agreement · Regulation FD disclosure
  8. 424B5 Offering Prospectus
  9. 4 Open-market buy Director bought 713,800 shares at $2.10 ($1,498,980)
  10. 144 Insider Sale of Securities
  11. 8-K Event Executive or director change
  12. 8-K Event Results of operations
  13. 10-K Report Annual Report
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Regulation FD disclosure
  16. 4 Open-market buy Director bought 45,000 shares at an average $4.31 ($193,794)
  17. 4/A Open-market buy Director bought 39,200 shares at an average $4.08 ($159,886)
  18. 4 Open-market buy Director bought 39,200 shares at an average $4.08 ($159,886)
  19. 4 Open-market buy Director bought 20,000 shares at an average $3.50 ($69,900)
  20. 4 Open-market buy Director bought 15,000 shares at $2.11 ($31,650)

Page 2 of 16 · 315 filings